Skip to main content

Table 2 Summary of primary and secondary outcomes and complications

From: Percutaneous transhepatic and endoscopic biliary drainage for malignant biliary tract obstruction: a meta-analysis

First author Year Definition of therapeutic success Therapeutic successa,% 30-day mortalitya,% Overall complicationsa,% Incidence of cholangitisa,% Incidence of pancreatitisa,%
Saluja 2008 Bilirubin declined to <50% of the pretreatment value within 7 days after drainage 89 vs. 41b 4 vs. 8 18 vs. 52b 11 vs. 48b 0 vs. 3.7
Piñol 2002 Bilirubin declined by ≥ 20% of the pretreatment value 71 vs. 42b 36 vs. 42 61 vs. 35 NA 0 vs. 3.8
Speer 1987 Bilirubin declined by ≥20% of the pretreatment value during the initial admission 61 vs. 81 33 vs.15 67 vs. 19b 13.9 vs. 17.9 NA
  1. aPercutaneous transhepatic biliary drainage vs. endoscopic biliary drainage. bSignificant difference between PTBD and EBD. NA, not available.